Search

Ziv Aliza Sandalon

from Rockville, MD
Age ~63

Ziv Sandalon Phones & Addresses

  • 12012 Gatewater Dr, Potomac, MD 20854
  • Rockville, MD
  • Glen Cove, NY
  • Glen Head, NY
  • 6121 145Th Ave, Bellevue, WA 98006 (425) 614-1291
  • Mercer Island, WA
  • Port Jefferson Station, NY
  • Kent, WA
  • Kiona, WA
  • 2 Salem Way, Glen Head, NY 11545

Work

Company: Coldwell Banker Address: 86 Glen Cove Road, East Hills, NY 11577 Phones: (425) 241-4339 (516) 625-2668

Education

Degree: Doctorates, Doctor of Philosophy School / High School: The Hebrew University of Jerusalem Specialities: Philosophy, Virology

Skills

Biotechnology • Assay Development • Drug Discovery • Molecular Biology • Immunology • Life Sciences • Virology • Clinical Development • Vaccines • Elisa • Cell Culture • Translational Research • Gene Therapy • Infectious Diseases • Cell Biology • In Vitro • In Vivo • Glp • Drug Development • Dna • Biopharmaceuticals • Animal Models • Genetics • Gmp • Antibodies • Protein Expression • Tissue Culture • Immunoassays • Inflammation • Ind • Team Management • Data Analysis • Sop • Biochemistry • Aav • Project Management • Pre Clinical • Adenovirus • Product Development Plan • Government Contracting • Technology Transfer • Pharmaceutical Industry • R&D • Pcr • Western Blotting • Microbiology • Process Qualification • Analytical Method Validation • Commercialization • Fda

Languages

English • Hebrew

Industries

Biotechnology

Specialities

Buyer's Agent • Relocation • Property Management

Professional Records

Real Estate Brokers

Ziv Sandalon Photo 1

Ziv Sandalon, East Hills NY Realtor

View page
Specialties:
Buyer's Agent
Relocation
Property Management
Work:
Coldwell Banker
86 Glen Cove Road, East Hills, NY 11577
(425) 241-4339 (Office), (425) 241-4339 (Cell), (516) 625-2668 (Fax)
Links:
Site
Twitter

Resumes

Resumes

Ziv Sandalon Photo 2

Senior Director Of Operations

View page
Location:
12012 Gatewater Dr, Rockville, MD 20854
Industry:
Biotechnology
Work:
Intrexon Corporation - Germantown, MD 2010 - 2012
Senior Translational Scientist, Human Therapeutic Division

SUNY Downstate Medical Center - Brooklyn, NY 2008 - 2010
Research Assistant Professor

International AIDS Vaccine Initiative (IAVI) - Brooklyn, NY 2007 - 2010
Principal Scientist

Targeted Genetics Corp. - Seattle, WA 2003 - 2006
Staff Scientist II

Targeted Genetics Corp. - Seattle, WA 2001 - 2003
Staff Scientist I
Education:
The Hebrew University of Jerusalem
Doctorates, Doctor of Philosophy, Philosophy, Virology
The Hebrew University of Jerusalem
Master of Science, Masters, Biotechnology
Ben - Gurion University of the Negev
Bachelors, Bachelor of Science, Biotechnology
Skills:
Biotechnology
Assay Development
Drug Discovery
Molecular Biology
Immunology
Life Sciences
Virology
Clinical Development
Vaccines
Elisa
Cell Culture
Translational Research
Gene Therapy
Infectious Diseases
Cell Biology
In Vitro
In Vivo
Glp
Drug Development
Dna
Biopharmaceuticals
Animal Models
Genetics
Gmp
Antibodies
Protein Expression
Tissue Culture
Immunoassays
Inflammation
Ind
Team Management
Data Analysis
Sop
Biochemistry
Aav
Project Management
Pre Clinical
Adenovirus
Product Development Plan
Government Contracting
Technology Transfer
Pharmaceutical Industry
R&D
Pcr
Western Blotting
Microbiology
Process Qualification
Analytical Method Validation
Commercialization
Fda
Languages:
English
Hebrew

Publications

Us Patents

Hybrid Adenovirus/Adeno-Associated Virus Vectors And Methods Of Use Thereof

View page
US Patent:
6916635, Jul 12, 2005
Filed:
Feb 12, 2001
Appl. No.:
09/782378
Inventors:
Patrick Hearing - St. James NY, US
Wadie F. Bahou - Setauket NY, US
Ziv Sandalon - Port Jefferson Station NY, US
Dmitri V. Gnatenko - Port Jefferson NY, US
Assignee:
The Research Foundation of State University of New York - Albany NY
International Classification:
C12N015/64
C12N015/09
C12N015/00
C12N015/63
C07H021/04
US Classification:
435 914, 435 6, 435 29, 4353201, 4352351, 435325, 435455, 536 231
Abstract:
The invention provides recombinant vectors including adenovirus/adeno-associated virus (Ad/AAV) vectors and mini-adenovirus (mAd) vectors. Further, the invention provides cells containing these vectors, and methods for making and using the vectors and cells. The compositions and methods of the invention are useful in transferring nucleotide sequences of interest into a cell, including, but not limited to, in gene therapy applications.

Hybrid Adenovirus/Adeno-Associated Virus Vectors And Methods Of Use Thereof

View page
US Patent:
7563617, Jul 21, 2009
Filed:
May 12, 2005
Appl. No.:
11/127832
Inventors:
Patrick Hearing - St. James NY, US
Wadie F. Bahou - Setauket NY, US
Ziv Sandalon - Bellevue WA, US
Dmitri V. Gnatenko - Port Jefferson NY, US
Assignee:
The Research Foundation Of State University of New York - Albany NY
International Classification:
C12N 15/861
C12N 5/00
C12N 7/01
A61K 31/713
A01N 63/00
US Classification:
4353201, 514 44, 435325, 4352351, 424 936
Abstract:
The invention provides recombinant vectors including adenovirus/adeno-associated virus (Ad/AAV) vectors and mini-adenovirus (mAd) vectors. Further, the invention provides cells containing these vectors, and methods for making and using the vectors and cells. The compositions and methods of the invention are useful in transferring nucleotide sequences of interest into a cell, including, but not limited to, in gene therapy applications.
Ziv Aliza Sandalon from Rockville, MD, age ~63 Get Report